“…The list indirectly demonstrates that no 'ideal' vector yet exists. New technology, including small interference RNA (siRNA), 31 adeno-associated virus inverted terminal repeat (AAV ITR)-based plasmids, 32,33 novel classes of lentivirus (equine infectious anemia virus-EIAV; feline immunodeficiency virus-FIV), [34][35][36][37][38][39][40] lentivirus-herpesvirus hybrids and other viral vectors is in development, but their efficiency has yet to be reported in the context of Figure 1 Multistep process of insulitis. During ontogeny, a population of thymocytes whose TCR recognize b-cell-specific antigens are either not deleted in the thymus, or fail to be tolerized subsequently, in the periphery.…”